Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis (JAKARTA)

This study has been completed.
Information provided by (Responsible Party):
Sanofi Identifier:
First received: September 16, 2011
Last updated: July 28, 2014
Last verified: July 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2014
  Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)
No publications provided by Sanofi

Publications automatically indexed to this study by Identifier (NCT Number):